Skip to main content
H.R. 4570 119th Congress House

Interagency Patent Coordination and Improvement Act of 2025

Official title: To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Admin… Show full official titleShow less

Official title: To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.

Introduced: July 21, 2025 Introduced by: Joe Neguse Democratic · Colorado See on congress.gov
Commerce
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 21, 2025
Referred to the House Committee on the Judiciary.
Jul 21, 2025
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now July 21, 2025

Referred to the House Committee on the Judiciary.

 Plain-English summary Congressional Research Service

Interagency Patent Coordination and Improvement Act of 2025

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.

 Related & companion bills 1
  • S 1097 Interagency Patent Coordination and Improvement Act of 2025
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 49

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 49 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-4570/
MLA
"H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-4570/.
Bluebook (legal)
H.R. 4570, 119th Cong. (2026), https://openamerica.io/bill/119-HR-4570/.
Markdown link
[H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025](https://openamerica.io/bill/119-HR-4570/)
Report a problem